ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2023, 'Combined Plasmapheresis and Complement Inhibition in a Highly Allosensitised Cardiac Transplant Recipient', Heart, Lung and Circulation, 32, pp. S147 - S148, http://dx.doi.org/10.1016/j.hlc.2023.06.057
,2023, 'Discrepancies in the Clinical and Histopathological Diagnosis of Cardiomyopathy in a Heart Transplant Cohort', Heart, Lung and Circulation, 32, pp. S152 - S152, http://dx.doi.org/10.1016/j.hlc.2023.06.068
,2023, 'Heart Transplantation Using Donation After Circulatory Death (DCD) Donors: St Vincent’s Hospital Experience Update', Heart, Lung and Circulation, 32, pp. S70 - S70, http://dx.doi.org/10.1016/j.hlc.2023.04.196
,2023, 'Initial Australian Experience With the XVIVO Non-Ischaemic Hypothermic Perfusion Device for Heart Preservation', Heart, Lung and Circulation, 32, pp. S2 - S3, http://dx.doi.org/10.1016/j.hlc.2023.04.012
,2023, 'Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant', Heart, Lung and Circulation, 32, pp. S164 - S164, http://dx.doi.org/10.1016/j.hlc.2023.06.095
,2023, 'Intraperitoneal Administration of Empagliflozin Reduces Myocardial Infarct Size in Mice', Heart, Lung and Circulation, 32, pp. S322 - S323, http://dx.doi.org/10.1016/j.hlc.2023.06.462
,2023, 'Routine Donor-Specific Antibody Monitoring in Heart Transplant Recipients: Is There a Role?', Heart, Lung and Circulation, 32, pp. S176 - S176, http://dx.doi.org/10.1016/j.hlc.2023.06.122
,2023, 'The Future of Biventricular Mechanical Circulatory Support', Heart, Lung and Circulation, 32, pp. S21 - S21, http://dx.doi.org/10.1016/j.hlc.2023.04.062
,2023, 'Use of Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Transplantation', Heart, Lung and Circulation, 32, pp. S23 - S23, http://dx.doi.org/10.1016/j.hlc.2023.04.067
,2022, 'Value of Renal Histology in Predicting Cardiorenal Outcomes in Heart Transplant-listed Patients', Transplantation Direct, 9, pp. E1424, http://dx.doi.org/10.1097/TXD.0000000000001424
,2022, 'Coronary angiography of the ex-situ beating donor heart in a portable organ care system', Catheterization and Cardiovascular Interventions, 100, pp. 1252 - 1260, http://dx.doi.org/10.1002/ccd.30455
,2022, 'Donation After Circulatory Death: A New Frontier', Current Cardiology Reports, 24, pp. 1973 - 1981, http://dx.doi.org/10.1007/s11886-022-01798-y
,2022, 'Expanding Donor Heart Utilization Through Machine Perfusion Technologies', Current Transplantation Reports, 9, pp. 219 - 226, http://dx.doi.org/10.1007/s40472-022-00375-0
,2022, 'Assessing the Relationship between Molecular Rejection and Parenchymal Injury in Heart Transplant Biopsies', Transplantation, 106, pp. 2205 - 2216, http://dx.doi.org/10.1097/TP.0000000000004231
,2022, 'Multispecies Outbreak of Nocardia Infections in Heart Transplant Recipients and Association with Climate Conditions, Australia', Emerging Infectious Diseases, 28, pp. 2155 - 2164, http://dx.doi.org/10.3201/eid2811.220262
,2022, 'Brain stem death induces pro-inflammatory cytokine production and cardiac dysfunction in sheep model', Biomedical Journal, 45, pp. 776 - 787, http://dx.doi.org/10.1016/j.bj.2021.10.007
,2022, 'Disseminated Aspergillus lentulus Infection in a Heart Transplant Recipient: A Case Report', Clinical Infectious Diseases, 75, pp. 1235 - 1238, http://dx.doi.org/10.1093/cid/ciac205
,2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
,2022, 'Clinician Estimates of Frailty Compared to Formal Frailty Assessment in Adults With Heart Failure: A Cross-Sectional Analysis', Heart Lung and Circulation, 31, pp. 1241 - 1246, http://dx.doi.org/10.1016/j.hlc.2022.04.003
,2022, 'Consensus statement on the current pharmacological prevention and management of heart failure', Medical Journal of Australia, 217, pp. 212 - 217, http://dx.doi.org/10.5694/mja2.51656
,2022, 'Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey', Clinical Transplantation, 36, http://dx.doi.org/10.1111/ctr.14733
,2022, 'Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation', Circulation, 145, pp. 1811 - 1824, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057006
,2022, 'Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies', European Heart Journal, 43, pp. 2237 - 2246, http://dx.doi.org/10.1093/eurheartj/ehac204
,2022, 'Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support', Journal of Heart and Lung Transplantation, 41, pp. 829 - 839, http://dx.doi.org/10.1016/j.healun.2022.02.008
,2022, 'Frailty Measures in Patients Listed for Lung Transplantation', Transplantation, 106, pp. 1084 - 1092, http://dx.doi.org/10.1097/TP.0000000000003823
,2022, 'Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial', The Lancet, 399, pp. 1391 - 1400, http://dx.doi.org/10.1016/S0140-6736(22)00369-5
,2022, 'Heart Transplant Donor Selection: Recent Insights', Current Transplantation Reports, 9, pp. 12 - 18, http://dx.doi.org/10.1007/s40472-022-00355-4
,2022, 'Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes', Journal of Heart and Lung Transplantation, 41, pp. 334 - 344, http://dx.doi.org/10.1016/j.healun.2021.08.004
,2022, 'Peripartum cardiomyopathy: a global effort to find the cause and cure for the rare and little understood disease', Biophysical Reviews, 14, pp. 369 - 379, http://dx.doi.org/10.1007/s12551-022-00930-0
,2022, 'Assessment of Omecamtiv Mecarbil for the Treatment of Patients with Severe Heart Failure: A Post Hoc Analysis of Data from the GALACTIC-HF Randomized Clinical Trial', JAMA Cardiology, 7, pp. 26 - 34, http://dx.doi.org/10.1001/jamacardio.2021.4027
,2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072
,2022, 'Prevention and Reversal of Frailty in Heart Failure', Circulation Journal, 86, pp. 14 - 22, http://dx.doi.org/10.1253/circj.CJ-21-0819
,2022, 'Validation of Cognitive Impairment in Combination with Physical Frailty as a Predictor of Mortality in Patients with Advanced Heart Failure Referred for Heart Transplantation', Transplantation, 106, pp. 200 - 209, http://dx.doi.org/10.1097/TP.0000000000003669
,2022, '212.6: Heart Transplantation Using Donation After Circulatory Death Donors – an 8 Year Experience', Transplantation, 106, pp. S24 - S24, http://dx.doi.org/10.1097/01.tp.0000885344.20619.e0
,2022, 'Machine Perfusion of Donor Hearts', Journal of Cardiac Failure, 28, pp. 9 - 9, http://dx.doi.org/10.1016/j.cardfail.2022.07.021
,2022, 'Midodrine to Treat Protein-Losing Enteropathy for Heart Transplant Candidacy', Heart, Lung and Circulation, 31, pp. S90 - S90, http://dx.doi.org/10.1016/j.hlc.2022.06.103
,2022, 'Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Supported With Left Ventricular Assist Devices', Heart, Lung and Circulation, 31, pp. S100 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.124
,2022, 'SODIUM RESTRICTION IN PATIENTS WITH HEART FAILURE:A SYSTEMATIC REVIEW AND META-ANALYSIS OFRANDOMIZED CLINICAL TRIALS', Canadian Journal of Cardiology, 38, pp. S168 - S169, http://dx.doi.org/10.1016/j.cjca.2022.08.124
,2022, 'Using Pulsatility Responses to Breath-Hold Manoeuvres to Predict Readmission Rates in Continuous-Flow Left Ventricular Assist Device Patients', Heart, Lung and Circulation, 31, pp. S105 - S106, http://dx.doi.org/10.1016/j.hlc.2022.06.139
,2021, 'Alarms and their outcomes in left Ventricular assist device patients', ASAIO Journal, 67, pp. 1284 - 1293, http://dx.doi.org/10.1097/MAT.0000000000001483
,2021, 'Applying a framework to assess the impact of cardiovascular outcomes improvement research', Health Research Policy and Systems, 19, http://dx.doi.org/10.1186/s12961-021-00710-4
,2021, 'Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis', Journal of Heart and Lung Transplantation, 40, pp. 1483 - 1494, http://dx.doi.org/10.1016/j.healun.2021.08.006
,2021, 'Frailty of the heart recipient', Transplantation, 105, pp. 2352 - 2361, http://dx.doi.org/10.1097/TP.0000000000003692
,2021, 'Predicting 10-year mortality in older adults using VO
2021, 'Therapeutic Inhibition of Acid Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury (vol 144, pg 947, 2021)', CIRCULATION, 144, pp. E211 - E211, http://dx.doi.org/10.1161/CIR.0000000000001020
,2021, 'Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury', Circulation, 144, pp. 947 - 960, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054360
,2021, 'Heart transplantation following donation after circulatory death: Expanding the donor pool', Journal of Heart and Lung Transplantation, 40, pp. 882 - 889, http://dx.doi.org/10.1016/j.healun.2021.03.011
,2021, 'Predicting 10-year mortality in older adults using VO2max, oxygen uptake efficiency slope and frailty class.', Eur J Prev Cardiol, 28, pp. 1148 - 1151, http://dx.doi.org/10.1177/2047487320914435
,2021, 'Frailty: A Dynamic Process in Aortic Stenosis?', Heart Lung and Circulation, 30, pp. 1110 - 1111, http://dx.doi.org/10.1016/j.hlc.2021.05.080
,2021, 'Phenotyping of Stable Left Ventricular Assist Device Patients Using Noninvasive Pump Flow Responses to Acute Loading Transients', Journal of Cardiac Failure, 27, pp. 642 - 650, http://dx.doi.org/10.1016/j.cardfail.2021.01.009
,